100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Ferric carboxymaltose is a non-dextran iron complex that gradually releases iron into the bloodstream. The released iron is utilized for the production of hemoglobin, myoglobin, and iron-containing enzymes, helping restore the body's iron reserves and improve oxygen transport.
Revofer 1g Injection is an intravenous iron replacement medicine containing ferric carboxymaltose. It is used to treat iron-deficiency anemia, particularly when oral iron is not tolerated, does not work adequately, or cannot be used. It replenishes the body's iron stores, which are essential for producing hemoglobin and red blood cells that transport oxygen throughout the body.
Revofer 1g Injection is administered into a vein by a doctor or trained healthcare professional. It should never be self-administered.
Depending on the patient's body weight and medical condition, treatment may be given as two doses approximately 7 days apart. The exact dose and treatment schedule should be determined by the physician.
Patients should generally be monitored during administration and for at least 30 minutes afterward for signs of an allergic or hypersensitivity reaction.
Pediatric safety and effectiveness have not been established.
Possible side effects include:
Most mild reactions are temporary, but persistent or troublesome symptoms should be reported to a healthcare professional.
Rarely, ferric carboxymaltose can cause serious hypersensitivity reactions, including anaphylaxis. Warning signs may include:
The injection should only be administered where appropriate emergency treatment is immediately available.
Excessive iron administration can cause iron overload and other complications. The medicine should therefore be administered only under medical supervision.
If you miss a scheduled treatment, contact your doctor or healthcare provider to determine when the next dose should be given. Do not administer an extra dose yourself.
Iron-deficiency anemia itself can cause complications during pregnancy, so treatment may be considered when clinically necessary. Available studies have not established a clear drug-related risk of major birth defects, but pregnancy use should be decided by a physician based on the potential benefits and risks.
Ferric carboxymaltose passes into breast milk in very small amounts, and available data have not identified harmful effects in breastfed infants. Consult your doctor before using it while breastfeeding.
Monitor blood pressure, hemoglobin, blood cells, and iron levels during treatment. Tell your doctor if you take oral iron supplements or other iron-containing medicines.
Store in a cool (below 30°C) & dry place, away from light. Do not freeze. Keep out of the reach of children.
⚠️Disclaimer:
At ePharma, we’re committed to providing accurate and accessible health information. However, all content is intended for informational purposes only and should not replace medical advice from a qualified physician. Please consult your healthcare provider for personalized guidance. We aim to support, not substitute, the doctor-patient relationship.